Marinus Pharma (MRNS) Tops Q1 EPS by 6c

Marinus Pharma (NASDAQ: MRNS) reported Q1 EPS of ($0.67), $0.06 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $10.38 million versus the consensus estimate of $5.76 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Methanex to idle Trinidad Titan plant after gas contract talks fail
• Hertz Global (HTZ) PT Lowered to $3.50 at Morgan Stanley